Sato Pharmaceutical Co., Ltd.
USPTO PatentsView assignee record - 11 granted patents across 10 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Sato ranks #25,137 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 10 technology areas.
- #25,137
- of 49,997 US assignees by volume
- Top 30%
- by Innovation Score (42.5/100)
- 15.7
- avg claims per patent
- +20%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R25137 · Foreign Corporation #25,137 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL
- GRANTS-MICRO 11 grants
- MID-PACK #25,137/49,997
- PHOTO-FINISH Sanrio
- CPC-FOCUS A61P · 10 areas
- INNOV-PAR 42.5/100
- CLAIMS-RICH 15.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-UP +20% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Sanrio Company, Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Sato’s 42.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Sato
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Advanced Upstream · near
Advanced Upstream · near
43 score
- Arc Suppression · near
Arc Suppression · near
43 score
- Humabs BioMed · near
Humabs BioMed · near
43 score
- Recurium IP Holdings · near
Recurium IP Holdings · near
43 score
- Sato Pharmaceutical · this assignee
Sato Pharmaceutical · this assignee
43 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Sato's Innovation Score is 42.5/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Sato?
Each dot is one of Sato’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sato’s own 15.7 claims/patent is ABOVE the 14.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Sato's grants concentrate
Sato Pharmaceutical Co., Ltd. is a focused PatentsView assignee: 10 CPC subclasses with 63.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2017. By volume, Sato sits between Sanrio Company, Ltd. and Scott Cutters Limited.
Sato's three-year grant acceleration
Sato Pharmaceutical Co., Ltd. shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Sato's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Sanrio
Sanrio Company, Ltd.
11 patents
- Sanwa Techno
Sanwa Techno Co., Ltd.
11 patents
- Sany Heavy Indust…
Sany Heavy Industry Co., Ltd.
11 patents
- Sasol WAX
Sasol WAX GMBH
11 patents
- Sauder Woodworking
Sauder Woodworking Co.
11 patents
- Schottky LSI
Schottky LSI, Inc.
11 patents
- Sciperio
Sciperio, Inc
11 patents
- Scott Cutters
Scott Cutters Limited
11 patents
- Sato Pharmaceutic… ◀
Sato Pharmaceutical Co., Ltd.
11 patents
What this shows Sato holds 11 patents at rank #25,114, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Sato
By rank, the assignees closest to #25,114 in granted patent volume.
- Sanrio Company, Ltd. #25,110 · 11 patents
- Sanwa Techno Co., Ltd. #25,111 · 11 patents
- Sany Heavy Industry Co., Ltd. #25,112 · 11 patents
- Sasol WAX GMBH #25,113 · 11 patents
- Sauder Woodworking Co. #25,115 · 11 patents
- Schottky LSI, Inc. #25,116 · 11 patents
- Sciperio, Inc #25,117 · 11 patents
- Scott Cutters Limited #25,118 · 11 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Sato's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Sato, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Sato ranks #2,588 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (43 here).
Sato's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 30% higher than 70% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 18.2% |
| 2016 | 2 | 18.2% |
| 2017 | 1 | 9.1% |
| 2021 | 2 | 18.2% |
| 2022 | 1 | 9.1% |
| 2023 | 3 | 27.3% |
Which technologies does Sato Pharmaceutical Co., Ltd. patent most?
Top 10 of 10 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Sato Pharmaceutical Co., Ltd.'s patent record in context - here's where to go next.
- Sato Pharmaceutical Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 63.6% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #25,137 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Sato Pharmaceutical Co., Ltd. against Sanrio Company, Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 42.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.